CN111529633A - A Chinese medicinal composition for treating chronic tracheitis and asthma - Google Patents
A Chinese medicinal composition for treating chronic tracheitis and asthma Download PDFInfo
- Publication number
- CN111529633A CN111529633A CN202010464406.0A CN202010464406A CN111529633A CN 111529633 A CN111529633 A CN 111529633A CN 202010464406 A CN202010464406 A CN 202010464406A CN 111529633 A CN111529633 A CN 111529633A
- Authority
- CN
- China
- Prior art keywords
- asthma
- herba
- parts
- treating
- traditional chinese
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 206010044302 Tracheitis Diseases 0.000 title claims abstract description 18
- 239000000203 mixture Substances 0.000 title claims abstract description 17
- 208000023819 chronic asthma Diseases 0.000 title description 2
- 239000003814 drug Substances 0.000 claims abstract description 32
- 208000006673 asthma Diseases 0.000 claims abstract description 23
- 229940079593 drug Drugs 0.000 claims abstract description 8
- 241000756943 Codonopsis Species 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 241001503991 Consolida Species 0.000 claims description 6
- 244000131316 Panax pseudoginseng Species 0.000 claims description 6
- 239000002775 capsule Substances 0.000 claims description 5
- 241000521581 Millettia Species 0.000 claims description 4
- 239000007788 liquid Substances 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 239000003826 tablet Substances 0.000 claims description 4
- 241000735527 Eupatorium Species 0.000 claims description 3
- 244000258070 Salvia viridis Species 0.000 claims description 3
- 235000001486 Salvia viridis Nutrition 0.000 claims description 3
- 239000006187 pill Substances 0.000 claims description 3
- 235000002789 Panax ginseng Nutrition 0.000 claims description 2
- 235000003181 Panax pseudoginseng Nutrition 0.000 claims description 2
- 241001448535 Reineckea carnea Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 16
- 231100000331 toxic Toxicity 0.000 abstract description 4
- 230000002588 toxic effect Effects 0.000 abstract description 4
- 210000004072 lung Anatomy 0.000 description 22
- 206010011224 Cough Diseases 0.000 description 19
- 206010006451 bronchitis Diseases 0.000 description 13
- 206010062717 Increased upper airway secretion Diseases 0.000 description 12
- 208000026435 phlegm Diseases 0.000 description 12
- 210000000952 spleen Anatomy 0.000 description 11
- 230000006870 function Effects 0.000 description 8
- 210000003734 kidney Anatomy 0.000 description 8
- 206010061218 Inflammation Diseases 0.000 description 7
- 230000004054 inflammatory process Effects 0.000 description 7
- 206010006458 Bronchitis chronic Diseases 0.000 description 6
- 208000007451 chronic bronchitis Diseases 0.000 description 6
- 208000024891 symptom Diseases 0.000 description 6
- 235000009508 confectionery Nutrition 0.000 description 5
- 210000003437 trachea Anatomy 0.000 description 5
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 4
- 235000003140 Panax quinquefolius Nutrition 0.000 description 4
- 206010036790 Productive cough Diseases 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 230000003467 diminishing effect Effects 0.000 description 4
- 235000008434 ginseng Nutrition 0.000 description 4
- 230000001988 toxicity Effects 0.000 description 4
- 231100000419 toxicity Toxicity 0.000 description 4
- 241001448537 Reineckea Species 0.000 description 3
- 210000004400 mucous membrane Anatomy 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 2
- 244000290333 Vanilla fragrans Species 0.000 description 2
- 235000009499 Vanilla fragrans Nutrition 0.000 description 2
- 235000012036 Vanilla tahitensis Nutrition 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 210000000621 bronchi Anatomy 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- MYSWGUAQZAJSOK-UHFFFAOYSA-N ciprofloxacin Chemical compound C12=CC(N3CCNCC3)=C(F)C=C2C(=O)C(C(=O)O)=CN1C1CC1 MYSWGUAQZAJSOK-UHFFFAOYSA-N 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 235000008216 herbs Nutrition 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 230000028327 secretion Effects 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 208000011580 syndromic disease Diseases 0.000 description 2
- 210000002435 tendon Anatomy 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- YSTPAHQEHQSRJD-UHFFFAOYSA-N 3-Carvomenthenone Chemical compound CC(C)C1CCC(C)=CC1=O YSTPAHQEHQSRJD-UHFFFAOYSA-N 0.000 description 1
- GSDSWSVVBLHKDQ-UHFFFAOYSA-N 9-fluoro-3-methyl-10-(4-methylpiperazin-1-yl)-7-oxo-2,3-dihydro-7H-[1,4]oxazino[2,3,4-ij]quinoline-6-carboxylic acid Chemical compound FC1=CC(C(C(C(O)=O)=C2)=O)=C3N2C(C)COC3=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-UHFFFAOYSA-N 0.000 description 1
- 241001533451 Ajuga ciliata Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010006482 Bronchospasm Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241001098027 Callerya speciosa Species 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000308663 Eupatorium fortunei Species 0.000 description 1
- 206010016807 Fluid retention Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- GSDSWSVVBLHKDQ-JTQLQIEISA-N Levofloxacin Chemical compound C([C@@H](N1C2=C(C(C(C(O)=O)=C1)=O)C=C1F)C)OC2=C1N1CCN(C)CC1 GSDSWSVVBLHKDQ-JTQLQIEISA-N 0.000 description 1
- 229930182555 Penicillin Natural products 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- GBFLZEXEOZUWRN-VKHMYHEASA-N S-carboxymethyl-L-cysteine Chemical compound OC(=O)[C@@H](N)CSCC(O)=O GBFLZEXEOZUWRN-VKHMYHEASA-N 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- JBDGDEWWOUBZPM-XYPYZODXSA-N ambroxol Chemical compound NC1=C(Br)C=C(Br)C=C1CN[C@@H]1CC[C@@H](O)CC1 JBDGDEWWOUBZPM-XYPYZODXSA-N 0.000 description 1
- 229960005174 ambroxol Drugs 0.000 description 1
- FQPFAHBPWDRTLU-UHFFFAOYSA-N aminophylline Chemical compound NCCN.O=C1N(C)C(=O)N(C)C2=C1NC=N2.O=C1N(C)C(=O)N(C)C2=C1NC=N2 FQPFAHBPWDRTLU-UHFFFAOYSA-N 0.000 description 1
- 229960003556 aminophylline Drugs 0.000 description 1
- 229960003022 amoxicillin Drugs 0.000 description 1
- LSQZJLSUYDQPKJ-NJBDSQKTSA-N amoxicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=C(O)C=C1 LSQZJLSUYDQPKJ-NJBDSQKTSA-N 0.000 description 1
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 1
- 229960000723 ampicillin Drugs 0.000 description 1
- 230000001088 anti-asthma Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000003385 bacteriostatic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229960003870 bromhexine Drugs 0.000 description 1
- OJGDCBLYJGHCIH-UHFFFAOYSA-N bromhexine Chemical compound C1CCCCC1N(C)CC1=CC(Br)=CC(Br)=C1N OJGDCBLYJGHCIH-UHFFFAOYSA-N 0.000 description 1
- 229940124630 bronchodilator Drugs 0.000 description 1
- 239000000168 bronchodilator agent Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 229960004399 carbocisteine Drugs 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- KMPWYEUPVWOPIM-UHFFFAOYSA-N cinchonidine Natural products C1=CC=C2C(C(C3N4CCC(C(C4)C=C)C3)O)=CC=NC2=C1 KMPWYEUPVWOPIM-UHFFFAOYSA-N 0.000 description 1
- 229960003405 ciprofloxacin Drugs 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 229940066493 expectorants Drugs 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001976 improved effect Effects 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 229960003376 levofloxacin Drugs 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003453 lung abscess Diseases 0.000 description 1
- 201000004792 malaria Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 229960001699 ofloxacin Drugs 0.000 description 1
- 238000000643 oven drying Methods 0.000 description 1
- LSQZJLSUYDQPKJ-UHFFFAOYSA-N p-Hydroxyampicillin Natural products O=C1N2C(C(O)=O)C(C)(C)SC2C1NC(=O)C(N)C1=CC=C(O)C=C1 LSQZJLSUYDQPKJ-UHFFFAOYSA-N 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 229940049954 penicillin Drugs 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 229930006968 piperitone Natural products 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000003908 quality control method Methods 0.000 description 1
- 230000002829 reductive effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 208000020029 respiratory tract infectious disease Diseases 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 208000013220 shortness of breath Diseases 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 208000024794 sputum Diseases 0.000 description 1
- 210000003802 sputum Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000008093 supporting effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/486—Millettia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating tracheitis and asthma, which is prepared from the following raw material medicines in parts by weight: herba Reineckeae Carneae, herba Coriandri, radix Flemingiae Philippinensis, radix Codonopsis Lanceolatae, herba Ajugae, herba Eupatorii Lindleyani, radix Rhodiolae Yunnanensis, and hispid Fig. The invention has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Description
Technical Field
The invention belongs to the technical field of traditional Chinese medicines, and particularly relates to a traditional Chinese medicine composition for treating tracheitis and asthma.
Background
Tracheitis (trachitis) is an inflammatory change of the mucous membrane of the trachea and the bronchus caused by non-infectious factors such as virus, bacterial infection, physical and chemical stimulation and the like, mucus secretion is increased, the activity of respiratory enzymes in the villus of the epithelium of the trachea mucous membrane is reduced due to the lack of negative ions, and the secretion function of the alveoli and the ventilation and air exchange functions of the lung are influenced. It is divided into acute and chronic. Acute tracheitis and bronchitis are acute inflammations of the mucous membranes of the trachea and the bronchus caused by biological or non-biological factors. Viral infection is a common cause, and the clinical manifestations are cough and expectoration. Chronic bronchitis refers to chronic nonspecific inflammation of the trachea, bronchial mucosa and surrounding tissues, and is clinically characterized by long-term cough, expectoration or asthma.
The treatment principle of western medicine in acute attack stage is mainly to control infection, dispel phlegm and relieve asthma. It is commonly used as penicillin for intramuscular injection, or orally taken anti-infective drugs such as amoxicillin, ampicillin or cephalexin, ciprofloxacin, ofloxacin or levofloxacin, bronchodilators, and expectorants such as ambroxol, carbocisteine, bromhexine, etc.
Western medicine takes effect quickly, but is easy to relapse, and treats the symptoms and the root causes.
Disclosure of Invention
The invention aims to improve the defects of the prior art and provides the traditional Chinese medicine composition for treating tracheitis and asthma, which has the characteristics of obvious treatment effect, short treatment period, no toxic or side effect and the like.
Tracheitis belongs to the category of cough, phlegm and fluid retention, asthma and other symptoms of traditional Chinese medicine.
The traditional Chinese medicine considers that the spleen has the function of promoting the absorption, transportation and transformation of body fluid of a human body. The weakened spleen function can lead to stagnation of water-dampness in the body. "dampness" can be converted into "drink", and "drink" can be further converted into "phlegm".
Under normal conditions, lung qi should descend to enter kidney, and kidney qi also has the function of absorbing and absorbing lung qi from upper part, so that the three coordinate to form qi movement to regulate respiration. If lung qi fails to descend or kidney qi fails to take up, it can lead to disorder of qi movement, which is also the cause of shortness of breath, cough and expectoration.
The external cause of trachitis is the attack of six pathogenic factors on the lung system, which fails to disperse and descend; the internal causes are the dysfunction of the spleen, lung and kidney due to lung deficiency. When the physiological functions of the whole body, especially the lung, are abnormal, the phlegm blocks the air passage, the lung qi is adverse up, the lung qi is not dispersed, and the lung is declined to descend, so that a series of symptoms and physical signs of chronic bronchitis appear. Therefore, the treatment of chronic tracheitis should address both the symptoms and root causes, so as to tonify lung, spleen and kidney; has the effects of eliminating phlegm, relieving cough and asthma, diminishing inflammation, clearing away heat and toxic materials and treating the symptoms.
Based on the theory, the technical scheme of the invention is as follows: an oral administration Chinese medicine for treating tracheitis and asthma, which is composed of the following raw material medicines in parts by weight:
6-18 parts of pink reineckea herb and herb of common bluebeard; 15-30 parts of beautiful millettia root and panax pseudoginseng; 30-60 parts of radix codonopsis pilosulae, carpet bugle, lindley eupatorium herb and hispid fig.
In a preferred embodiment, the traditional Chinese medicine composition for treating sphagitis and tonsillitis is composed of the following raw material medicines in parts by weight:
18 parts of pink reineckea herb and herb of common bluebeard; 30 parts of beautiful millettia root and huanyang ginseng; lanhuashen, carpet bugle, lindley eupatorium herb and Wuzhimaotao 60 parts.
Wherein, the blue flower ginseng: sweet and mild in taste. Replenishing qi to invigorate the spleen, relieving cough and eliminating phlegm, relieving exterior syndrome and tonifying lung, stopping bleeding and checking malaria. Can be used for treating asthenia, bronchitis, cough due to lung deficiency, etc.
B, eupatorium fortunei: is bitter in taste; the nature is mild. Tonifying lung and relieving cough; resolving phlegm and relieving asthma; reducing blood pressure. For bronchitis; cough with profuse sputum, etc.
Radix fici simplicissimae is sweet in taste; the nature is mild. Invigorating spleen and lung; promoting qi circulation and eliminating phlegm; relaxing tendons and activating collaterals. Treating edema due to spleen deficiency; cough due to pulmonary tuberculosis; chronic bronchitis, and the like.
Beautiful millettia root: sweet and mild in taste. Tonify deficiency and moisten lung, strengthen tendons and activate collaterals. Can be used for treating pulmonary tuberculosis, chronic bronchitis, etc.
Lucky grass: sweet and mild in taste. Moisten lung to arrest cough, dispel wind, join bones. Can be used for treating pulmonary tuberculosis, cough, hemoptysis, chronic bronchitis, asthma, etc.
Herb of Yunnan Vanilla: pungent, slightly bitter and warm in flavor. Relieving cough and asthma, diminishing inflammation, relieving pain, dispelling wind and promoting diuresis. Can be used for treating bronchitis, chronic bronchitis, etc. The herba Cymbopogonis Citrari preparation has obvious effect of relieving asthma and resisting allergic bronchospasm. Cough relieving and phlegm eliminating are less frequent, and they also have some bacteriostatic action. Containing piperitone
Ajuga reptans: bitter and cold in flavor. Clear heat and remove toxicity, cool blood and pacify liver. Can be used for treating upper respiratory infection, bronchitis, pneumonia, lung abscess, etc. Ajuga ciliata is bitter in taste, has strong effects of clearing heat and removing toxicity, and has good curative effect on acute bronchitis. The carpet bugle can directly inhibit the cough center, and has similar cough relieving effect strength with codeine; can reduce permeability of trachea during inflammation, and has effects of diminishing inflammation and eliminating phlegm. Can directly dilate bronchial smooth muscle, and has antiasthmatic effect similar to aminophylline. Has obvious function of enhancing immunity. Has inhibitory effect on Staphylococcus aureus, alpha hemolytic streptococcus, Catalpoccus, pneumococcus, and Pseudomonas aeruginosa.
And (3) radix ginseng: is bitter in taste; sweet; is cool in nature. Replenishing qi and blood, invigorating spleen and stomach, invigorating kidney, supporting yang, relieving cough and asthma. Can be used for treating bronchitis.
Radix Codonopsis Lanceolatae, herba Eupatorii Lindleyani, and radix fici Simplicissimae for tonifying lung; radix Panacis Quinquefolii, hispid Fig, and radix Rhodiolae Yunnanensis for invigorating spleen; huanyang ginseng also has the functions of tonifying kidney and strengthening yang, and the four traditional Chinese medicines are monarch medicines for treating root causes. Millettia speciosa and pink reineckea herbs moisten lung to arrest cough; the herb of Yunnan Vanilla can relieve cough and asthma and diminish inflammation; ajuga reptans is a ministerial drug for clearing heat and removing toxicity.
The Chinese medicinal composition for treating tracheitis and asthma is prepared from Chinese traditional Chinese medicinal herbs according to a plurality of principles of traditional Chinese medicine treatment based on syndrome differentiation and modern medicine, and is formed by orderly matching certain natural extracts with definite components and clear effects.
The invention has the functions of invigorating qi and spleen, nourishing lung and moistening lung, reducing phlegm and eliminating phlegm, and relieving cough and asthma; the traditional Chinese medicine composition has the effects of diminishing inflammation, tonifying kidney and strengthening yang, clearing heat and removing toxicity, can enhance the immune function of organisms, effectively treat tracheitis, asthma and the like, is safe and reliable, does not have obvious toxic or side effect, does not hurt the spleen and the stomach, is convenient for patients to insist on taking for a long time, treats both principal and secondary aspect of disease, and is not easy to relapse.
The traditional Chinese medicine composition has the advantages of small number of medicines, easily obtained raw materials, simple process, low cost and high efficiency, and is beneficial to pharmaceutical enterprises to carry out medicine production and quality control; the product has low price and is easy to be accepted by patients.
The traditional Chinese medicine composition has remarkable effect of treating tracheitis and asthma, and clinical experiment results show that the prescription is used for treatment, one dose of the traditional Chinese medicine composition is decocted with 100 ml of water for one dose every day, the traditional Chinese medicine composition is divided into two parts, the medicine composition is taken one part in the morning and at night, one month is a treatment course, the cure rate of 5-6 treatment courses is 56%, the close control and significant efficiency is 88%, the total effective rate is 100%, and symptoms of pharyngalgia, pharyngeal dryness, pharyngeal itching, foreign body sensation, pharyngeal mucosa congestion, edema and the like of patients after treatment by a treatment group are remarkably improved.
The treatment cost of the invention is relatively low and is far lower than that of western medicine.
The invention also provides an oral preparation prepared from the traditional Chinese medicine composition for treating tracheitis and asthma, which comprises oral liquid, tablets, capsules, pills and the like, preferably the dosage forms are tablets and capsules, and one dose is taken every day in the morning and at night.
The traditional Chinese medicine composition can be prepared into various dosage forms. For example, the decocted liquid medicine is sterilized and disinfected and then packaged to prepare oral liquid; or concentrating the decoction, oven drying, adding pharmaceutically acceptable adjuvants, and making into tablet, capsule, pill, etc.
The medically acceptable auxiliary materials comprise starch, dextrin, sodium carboxymethylcellulose, polyethylene glycol, calcium hydrophosphate, sodium alginate, potassium sorbate and the like.
The above description is only for the purpose of illustrating the preferred embodiments of the present invention and is not to be construed as limiting the present invention in any way, and it will be apparent to those skilled in the art that the above description of the present invention can be applied to various modifications, equivalent variations or modifications without departing from the spirit and scope of the present invention.
Claims (4)
1. A traditional Chinese medicine composition for treating tracheitis and asthma is characterized by comprising the following components: herba Reineckeae Carneae, herba Coriandri, radix Flemingiae Philippinensis, radix Codonopsis Lanceolatae, herba Ajugae, herba Eupatorii Lindleyani, caulis et folium Gaultheriae Yunnanensis, and hispid Fig.
2. The traditional Chinese medicine for treating tracheitis and asthma as claimed in claim 1, which is characterized by comprising the following raw material medicines in parts by weight: 6-18 parts of pink reineckea herb and herb of common bluebeard; 15-30 parts of beautiful millettia root and panax pseudoginseng; 30-60 parts of radix codonopsis pilosulae, carpet bugle, lindley eupatorium herb and hispid fig.
3. An oral preparation for treating tracheitis and asthma, which is prepared from the Chinese medicinal composition of any one of claims 1 or 2.
4. The oral preparation for treating tracheitis and asthma according to claim 3, which comprises oral liquid, tablet, capsule and pill, preferably capsule and tablet.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010464406.0A CN111529633A (en) | 2020-05-28 | 2020-05-28 | A Chinese medicinal composition for treating chronic tracheitis and asthma |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010464406.0A CN111529633A (en) | 2020-05-28 | 2020-05-28 | A Chinese medicinal composition for treating chronic tracheitis and asthma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN111529633A true CN111529633A (en) | 2020-08-14 |
Family
ID=71969558
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010464406.0A Pending CN111529633A (en) | 2020-05-28 | 2020-05-28 | A Chinese medicinal composition for treating chronic tracheitis and asthma |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN111529633A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113633730A (en) * | 2021-09-29 | 2021-11-12 | 浙江养和健康管理科技有限公司 | Traditional Chinese medicine composition for treating asthma and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079645A (en) * | 2015-09-07 | 2015-11-25 | 杨士柏 | Traditional Chinese medicinal composition for treating capillary bronchitis with syndrome of accumulation of phlegm heat |
| CN105770455A (en) * | 2016-05-04 | 2016-07-20 | 李双 | Traditional Chinese medicinal preparation for treating bronchial asthma |
| CN107057988A (en) * | 2017-03-02 | 2017-08-18 | 广东金山百草健康产业有限公司 | A kind of beautiful millettia root health liquor and preparation method thereof |
-
2020
- 2020-05-28 CN CN202010464406.0A patent/CN111529633A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105079645A (en) * | 2015-09-07 | 2015-11-25 | 杨士柏 | Traditional Chinese medicinal composition for treating capillary bronchitis with syndrome of accumulation of phlegm heat |
| CN105770455A (en) * | 2016-05-04 | 2016-07-20 | 李双 | Traditional Chinese medicinal preparation for treating bronchial asthma |
| CN107057988A (en) * | 2017-03-02 | 2017-08-18 | 广东金山百草健康产业有限公司 | A kind of beautiful millettia root health liquor and preparation method thereof |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113633730A (en) * | 2021-09-29 | 2021-11-12 | 浙江养和健康管理科技有限公司 | Traditional Chinese medicine composition for treating asthma and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1843499A (en) | Traditional Chinese medicine formulation for treating bronchitis and tonsillitis | |
| CN111544540A (en) | Medicine for resisting novel coronavirus, preparation method and application thereof | |
| CN100333770C (en) | Medicine for preventing and curing laryngolaryngitis and its preparation method | |
| CN111529633A (en) | A Chinese medicinal composition for treating chronic tracheitis and asthma | |
| CN100418567C (en) | Medicine for treating cold and cough and its prepn process | |
| CN103705890A (en) | Pharmaceutical composition with function of removing heat from lung to relieve cough | |
| CN114632129B (en) | Traditional Chinese medicine for treating pediatric cough variant asthma and preparation method thereof | |
| CN1150927C (en) | Stomatopathy and throat disease treating health care medicine and its production process | |
| CN102641335A (en) | Traditional Chinese medicine composition for treating upper respiratory tract viral infection and preparation method thereof | |
| CN102526236B (en) | Pharmaceutical formulation for treating influenza and preparation method thereof | |
| CN104587204A (en) | Traditional Chinese medicine for treating wind heat cough and preparation method of sugar syrup comprising traditional Chinese medicine | |
| CN104274750B (en) | A kind of Chinese medicine composition for treating acute bronchitis, the infection of the upper respiratory tract | |
| CN109106774B (en) | Traditional Chinese medicine composition for treating adenoidal hypertrophy and complications thereof, and preparation method and application thereof | |
| CN102380075A (en) | Chinese medicine for treating child respiratory system infection and inflammation | |
| CN105879000A (en) | Pharmaceutic preparation for treating tonsillitis and application thereof | |
| CN102614322B (en) | Medicinal composition for treating child asthmatic suffocating pneumonia | |
| CN111529601A (en) | Traditional Chinese medicine composition for treating emphysema | |
| CN108815329A (en) | A kind of Chinese medicine composition and preparation method thereof for treating flu | |
| CN105343485A (en) | Medicine composition for treating nasosinusitis and application thereof | |
| CN1256132C (en) | Chinese medicinal preparation for treating infant tracheitis | |
| CN104189610A (en) | Traditional Chinese medicine composition for treating bronchitis | |
| CN1895604A (en) | Antasthmatic | |
| CN112972541A (en) | A Chinese medicinal composition for treating common cold with fever, pharyngolaryngitis and tonsillitis | |
| CN105477625A (en) | Dust adsorption and removal Chinese herbal medicine preparation and preparation method thereof | |
| CN104398610A (en) | Medicament for treating cough and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |